Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orkila is a leading distributor of specialty chemicals and ingredients, with a significant focus on the life sciences, pharmaceutical, and healthcare sectors across the Middle East and Africa. The company provides a comprehensive range of products, including active pharmaceutical ingredients (APIs), excipients, and diagnostic equipment, serving as a critical link between global manufacturers and local healthcare providers. In 2020, Orkila was acquired by the Azelis Group, a global leader in the specialty chemicals distribution industry, further expanding its reach and technical capabilities. Today, the company operates as a specialized division within Azelis, continuing to support the development and distribution of healthcare solutions in emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OrKli Hospital Company.